Journalism of Courage
Biocon
Follow on:
Biocon Limited: A Pioneer in Indian Biopharmaceuticals Biocon Limited, founded in 1978 by Kiran Mazumdar-Shaw, has established itself as a leading biopharmaceutical company based in Bengaluru. Its operations span a global reach, with generic active pharmaceutical ingredients (APIs) distributed acros...
Image Source : Wikipedia
- Company type Public
- Founded 1978 (47 years ago) (1978)
- Founders Kiran Mazumdar-Shaw
- Headquarters Bangalore, Karnataka, India
- Key people Kiran Mazumdar-Shaw (executive chairperson), Peter Bains (Group CEO), Siddharth Mittal (CEO & (CEO &
- Revenue ₹15,621 crore (US$1.8 billion) (FY24)
- Net income ₹1,030 crore (US$120 million) (FY24)
- Number of employees 16,545 <small>(March 2023)</small>
- Subsidiaries Biocon Biologics, Syngene International
- Website www.biocon.com
Related Other Pages:
Biocon history
Last Updated : 17/03/25, 05:12 AM
Biocon: A Journey in Biopharmaceutical Innovation Founded in 1978 by Kiran Mazumdar-Shaw with a modest US$10,000, Biocon quickly established itself as a pioneer in the Indian biotechnology sector. Early successes included becoming the first Indian company to export enzymes to the US and Europe (1979...
BIOCON NEWS
Biocon founder Kiran Mazumdar-Shaw says purchased electoral bonds at personal level, firm not involved
March 18, 2024 11:19 am
Kiran Mazumdar-Shaw was responding to reports that Biocon had donated to the JD(S) through electoral bonds.
Serum Institute of Life Sciences to double investment in Biocon's unit to $300 million
April 25, 2023 10:31 am
Biocon had signed an agreement in September 2021 to offer about 15% stake in Biocon Biologics to Serum Institute of Life Sciences.
Bengaluru: John Shaw, husband of Biocon founder Kiran Mazumdar Shaw, passes away
October 26, 2022 9:36 am
John Shaw had served as a foreign promoter of the company and was a member of the board of directors of Biocon since 1999. He was born in 1949 and was a postgraduate from Glasgow University.
Biocon bribery case: Credibility of circumstantial evidence has to be assessed, says HC, grants bail to 3
September 07, 2022 3:11 am
On CBI’s case that the accused were caught red-handed, the court said it cannot be overlooked that the alleged recovery in the case is “not pursuant to any usual trap proceedings”.
CBI files charge sheet in Biocon case
August 25, 2022 10:29 am
The bribe was allegedly for favourably recommending the file of Insulin Aspart Injection to the Subject Expert Committee (SEC) meeting on May 18 for waiving the phase 3 clinical trial.
Joint drug controller detained by CBI in bribery case, Biocon Biologics executive among booked
June 21, 2022 7:04 am
Mazumdar-Shaw, Biocon Biologics reject charge: Meeting minutes in public domain.
Biocon arm to buy Viatris’ biosimilars business for $3.3 bn
March 01, 2022 12:27 am
US-based Viatris will receive cash consideration of $ 2 billion on closing of the transaction and up to $335 million as additional payments expected to be paid in 2024.
Biocon ties up with diabetes research society for care programme
November 16, 2021 11:48 am
India has among the largest population of children and adolescents with Type 1 diabetes in the world with an estimated 1 million children and adolescents with this condition as of 2019.
Input costs, slow sales crimp India Inc profits
August 02, 2021 10:44 am
The Q1FY22 numbers must be read in the context of the very weak base from a year-on-year perspective and a slightly strong base effect on a quarter-on-quarter basis.
Antibody for Covid-19 curb, treatment: Biocon Biologics partners with Adagio Therapeutics
July 26, 2021 9:08 pm
ADG20 is in global clinical development by Adagio as a single agent for both the treatment and prevention of Covid-19, the disease caused by the SARS-CoV-2 virus, its variants, as well as future variants that may emerge.
